Prognosis of asymptomatic patients who underwent a sodium channel blocker challenge.

13 April 2026 (08:30 - 09:15)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor Vincent Probst

University Hospital of Nantes, Nantes (France)

6 More presentations in this session

Presentation thumbnail

Incidence and predictors of major arrhythmic events following acute myocarditis complicated by ventricular arrhythmias: a systematic review and meta-analysis.

Miss S. M'Rabet (Dijon, FR)

Abstract Slides Video

Presentation thumbnail

Predictors and outcomes of electrical storm in patients with sustained ventricular arrhythmias during acute myocardial infarction

Professor C. Guenancia (Dijon, FR)

Abstract Slides Video

Presentation thumbnail

Arrhythmic genotypes and risk of major ventricular arrhythmia in dilated cardiomyopathy: a multicentre japanese cohort

Mr K. Kanaoka (Suita, JP)

Abstract Slides Video

Presentation thumbnail

Phenotypic clustering using cardiac magnetic resonance imaging differentiates genetic background and outcomes in dilated cardiomyopathy.

Doctor E. Goethals (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Prevalence and characteristics of the catecholamine induced QT prolongation syndrome

Professor J. Gourraud (Nantes, FR)

Abstract Slides Video

Access the full session

Session thumbnail

Ventricular arrhythmias: epidemiology, prognosis, outcome

The Event

Event poster

EHRA 2026

13 April 2026 08:30 CET

You may be interested in

Congress Presentation

Asymptomatic Brugada patients: long-term prognosis from a large prospective study.

Congress Presentation

When should you do a sodium channel blocker challenge?

Congress Presentation

Prognosis of Brugada patients according to their SCN5A genetic status.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources